GEMMABio Secures $34 Million in Seed Funding to Drive Gene Therapy Advancements
December 26, 2024
GEMMA Biotherapeutics (“GEMMABio”) – a new therapeutics company founded by gene therapy pioneer Dr. Jim Wilson – announced the completion of a $34 million seed funding round to accelerate its